![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcVVGIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--29ad494aeacf13a345746f9e3e2644a9a2da5021/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Canaan.com%20Company%20Logos.png)
Axcelius I/II
Axcelius I/II is company creation vehicle with a focus on Biopharmaceutical companies pursing treatments for cancer, rare diseases, and neurodegenerative disorders.
Axcelius I/II is company creation vehicle with a focus on Biopharmaceutical companies pursing treatments for cancer, rare diseases, and neurodegenerative disorders.